FORM DEF 14A

Company

Altimmune, Inc.

Filed

April 30, 2013

Period of Report

June 11, 2013

Accession Number

0001144204-13-025086

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →